Medicines Marketed by Eris Lifesciences Ltd

About Eris Lifesciences Ltd

Eris Lifesciences Ltd is a leading player in the Indian pharmaceutical industry, operating in the healthcare sector since its establishment in 2007. Based in Ahmedabad, Gujarat, the company has a strong presence in the domestic market, particularly in the branded formulation segment, catering to a wide range of consumers needing chronic and sub-chronic therapies.

Despite being established just 17 years ago, Eris Lifesciences Ltd has quickly risen to become a prominent figure in the Indian Pharmaceutical Market (IPM), currently ranking #20. The company's commitment to innovation, diversification, and addressing significant health needs in India has positioned it as a formidable player in the industry.

Eris Lifesciences Ltd Products

Eris Lifesciences Ltd has a diversified product portfolio that covers about 90% of India's Rs. 55,000+ crore chronic care market. The company's core focus is on its cardio-metabolic franchise, which includes products for hypertension, anti-diabetes, metabolic disorders, and lipid-lowering therapies. These products are central to the company's revenue, reflecting its expertise in managing chronic lifestyle-related diseases.

In addition to its cardio-metabolic franchise, Eris Lifesciences Ltd is also expanding into emerging therapeutic areas such as dermatology, neuropsychiatry, women's health, and nephrology, which account for approximately 29% of the company's revenue. The majority of its revenue comes from chronic and sub-chronic therapies, which account for around 86% of its total revenue. The company's focus on chronic disease management sets it apart, as it addresses a critical need in the Indian healthcare market, making a meaningful impact in the management of lifestyle-related diseases.